STOCK TITAN

Intercept to Announce Second Quarter 2022 Financial Results on August 3, 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Intercept Pharmaceuticals (Nasdaq: ICPT) will announce its second quarter 2022 financial results before market open on August 3, 2022. Following the announcement, a conference call will be held at 8:30 a.m. ET to discuss the results. Investors can access the live webcast via the company's investor page. During the event, participants are encouraged to join 10 minutes early. A replay will be available shortly after the call and will remain accessible for a year.

Positive
  • Scheduled announcement of Q2 2022 financial results, demonstrating transparency.
  • Conference call allows direct communication with management, enhancing investor engagement.
Negative
  • None.

MORRISTOWN, N.J., July 27, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its second quarter 2022 financial results prior to market open on Wednesday, August 3, 2022. The announcement will be followed by a conference call and audio webcast hosted by Intercept management at 8:30 a.m. ET to discuss the results.

Participants can access the conference call live via webcast which will be available on the investor page of our website at http://ir.interceptpharma.com. Participants who wish to ask a question may register here to receive dial-in numbers and a unique pin to join the call. While not required, it is recommended you join 10 minutes prior to the event's start. A replay of the call will be available on our website shortly following the completion of the call and will be available for one year. 

About Intercept 
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn. 

Contact 
For more information about Intercept, please contact: 

For investors: 
Nareg Sagherian, Executive Director, Global Investor Relations 
investors@interceptpharma.com

For media: 
Karen Preble, Executive Director, Global Corporate Communications 
media@interceptpharma.com 


FAQ

When will Intercept Pharmaceuticals announce its Q2 2022 financial results?

Intercept Pharmaceuticals will announce its Q2 2022 financial results on August 3, 2022.

What time is the conference call for Intercept Pharmaceuticals' Q2 2022 results?

The conference call will take place at 8:30 a.m. ET on August 3, 2022.

How can I access the webcast for the Intercept Pharmaceuticals conference call?

The webcast can be accessed via the investor page on Intercept Pharmaceuticals' website.

Will there be a replay available for the Intercept Pharmaceuticals conference call?

Yes, a replay of the call will be available shortly after its completion and can be accessed for one year.

Intercept Pharmaceuticals, Inc.

NASDAQ:ICPT

ICPT Rankings

ICPT Latest News

ICPT Stock Data

794.69M
40.45M
3.13%
81.3%
24.24%
Biotechnology
Healthcare
Link
United States
Morristown